IDEX BIOMETRICS ASA (IDEX.OL) Stock Balance Sheet
OSL:IDEX - Euronext Oslo - NO0013107490 - Common Stock - Currency: NOK
| MRQ (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | 1.08M | 11.35M | 16.12M | 33.76M | 7.30M | |||
| Receivables | 1.90M | 1.93M | 2.28M | 1.50M | 1.65M | |||
| Inventories | 6.41M | 6.38M | 4.45M | 1.23M | 859.00K | |||
| Other Current Assets | 1.18M | 648.00K | 986.00K | 851.00K | 1.03M | |||
| Total Current Assets | 10.56M | 20.31M | 23.84M | 37.35M | 10.84M | |||
| Non-Current Assets | ||||||||
| PPE Net | 724.00K | 2.59M | 2.65M | 1.66M | 2.68M | |||
| Goodwill | 968.00K | 968.00K | 968.00K | 968.00K | 968.00K | |||
| Intangibles | 653.00K | 1.01M | 1.49M | 1.97M | 2.44M | |||
| Other Non-Current Assets | -1.00K | -1.00K | N/A | N/A | N/A | |||
| Total Non-Current Assets | 2.43M | 4.65M | 5.18M | 4.68M | 6.17M | |||
| TOTAL ASSETS | 12.99M | 24.96M | 29.02M | 42.03M | 17.01M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 5.08M | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 452.00K | 624.00K | 402.00K | 362.00K | 731.00K | |||
| Accrued Expenses | N/A | N/A | N/A | N/A | 0.00 | |||
| Accounts Payable | 2.30M | 688.00K | 1.54M | 685.00K | 631.00K | |||
| Other Current Liabilities | 2.13M | 6.00M | 3.09M | 3.24M | 2.80M | |||
| Total Current Liabilities | 4.88M | 12.39M | 5.03M | 4.29M | 4.17M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 1.98M | 1.24M | 1.14M | 11.00K | 327.00K | |||
| Deferred Taxes/Income | N/A | N/A | N/A | N/A | 0.00 | |||
| Other Non-Current Liabilities | 399.00K | N/A | N/A | N/A | N/A | |||
| Total Non-Current Liabilities | 2.38M | 1.24M | 1.14M | 11.00K | 327.00K | |||
| TOTAL LIABILITIES | 7.26M | 13.63M | 6.17M | 4.30M | 4.49M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -340.76M | -330.03M | -303.40M | -1.24M | -14.69M | |||
| Additional Paid In Capital | 5.21M | 2.12M | 4.04M | 9.45M | 3.61M | |||
| Common Shares | 12.41M | 25.95M | 22.76M | 20.41M | 17.25M | |||
| Other Shareholders' Equity | 328.87M | 313.29M | 299.44M | 9.10M | 6.34M | |||
| Shares Outstanding | 440.37M | 279.84M | 233.63M | 203.29M | 166.43M | |||
| Tangible Book Value per Share | 0.01 | 0.03 | 0.09 | 0.17 | 0.05 | |||
| Total Shareholders' Equity | 5.73M | 11.33M | 22.84M | 37.73M | 12.51M | |||
| TOTAL LIABILITIES AND EQUITY | 12.99M | 24.96M | 29.02M | 42.03M | 17.01M | |||
| Statistics | ||||||||
| Debt/Equity | 0.34 | 0.56 | 0.05 | 0.00 | 0.03 | |||
| Current Ratio | 2.16 | 1.64 | 4.74 | 8.71 | 2.60 | |||
| Return On Assets (ROA) | -120.44% | -106.68% | -112.57% | -77.46% | -157.32% | |||
| Return On Equity (ROE) | -272.88% | -234.95% | -143.00% | -86.29% | -213.79% | |||
All data in USD (non-GAAP EPS in NOK ) , ROIC based on taxRate of 0.23